Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

NCT01067287

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Rambam Medical Center Haifa, Israel

View Trial Details

Completed

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens

NCT01502085

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

NCT01813227

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT

NCT01242267

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

NCT01315132

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

NCT03441958

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Montreal, Quebec, Canada

View Trial Details

Completed

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

NCT01615029

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Boston, Massachusetts, United States

Copenhagen Ø, Denmark

Vejle, Denmark

Lille, France

View Trial Details

Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions: Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations: Rush University Medical Center Chicago, Illinois, United States

University of Chicago Chicago, Illinois, United States

Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States

NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Completed

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

NCT01572480

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

EHealth Educational Intervention to Improve Self-Management and Coping Behaviors Among Cancer Patients

NCT07457112

Conditions: Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +30 more
Locations: Faculty of Nursing Zagazig, Egypt

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions